MTOR and cancer: Repurposing of the antifungal agent ICZ for cancer has been based on the identification of several potential cancer targets, including the Hedgehog and the mTOR pathways (Head et al., 2015; Kim et al., 2010), but not on its action on proteins of the OSBP family.